美国的肺癌结果差别很大,有些州的情况有所改善,而另一些州则在筛查、生存和公平方面面临重大挑战。 U.S. lung cancer outcomes vary widely, with some states improving while others face major challenges in screening, survival, and equity.

美国肺癌协会2025年的 " 肺癌状况 " 报告揭示了美国各州在肺癌筛查、存活和获得治疗方面存在的巨大差距。 The American Lung Association’s 2025 “State of Lung Cancer” report reveals significant disparities across U.S. states in lung cancer screening, survival, and treatment access. 缅因州在筛查率方面排在第五位,但只有24%的合格居民每年接受低剂量CT扫描,尽管已证明有拯救生命的好处。 Maine ranks fifth in screening rates but only 24% of eligible residents get annual low-dose CT scans, despite proven life-saving benefits. 奥克拉荷马州在筛查、生存和早期诊断方面排名接近底部,而爱荷华州面临着高吸烟率和暴露的挑战。 Oklahoma ranks near the bottom in screening, survival, and early diagnosis, while Iowa faces challenges with high smoking rates and radon exposure. 宾夕法尼亚州取得了进步,5年存活率提高了27%,全国排名第九,尽管它仍然是和吸烟的顶级州。 Pennsylvania shows progress with a 27% improvement in five-year survival, ranking ninth nationally, though it remains a top state for radon and smoking. 专家们强调早期发现、扩大筛查和生物标志测试保险的重要性,以改善结果,特别是对于从未吸烟者和服务不足的人口而言。 Experts stress the importance of early detection, expanded screening access, and insurance coverage for biomarker testing to improve outcomes, especially for never-smokers and underserved populations.